Literature DB >> 26588983

Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.

Ian P Clements1, Anita A Kelkar2, Ernest V Garcia3, Javed Butler4, Ji Chen3, Russell Folks3, Arnold F Jacobson5.   

Abstract

AIMS: The purpose of this study was to examine the prognostic significance of uptake patterns on quantitative myocardial (123)I-mIBG and (99m)Tc-tetrofosmin SPECT imaging in heart failure (HF) subjects and to assess the differences between patients with ischaemic and non-ischaemic HF. METHODS AND
RESULTS: Results of quantitative analyses of (123)I-mIBG myocardial SPECT, alone and in combination with (99m)Tc tetrofosmin SPECT, were studied in 619 ischaemic (I) and 319 non-ischaemic (NI) HF subjects from the ADMIRE-HF trial. Cardiac and all-cause mortality data for 2-year follow-up were collected in the extension study (ADMIRE-HFX) and were examined in relation to extent and severity of voxel-based defects, the number of myocardial segments with significant dysinnervation (derived score ≥2), and (123)I-mIBG/(99m)Tc tetrofosmin mismatch quantitation. Cox proportional hazards and survival analyses were used to identify higher and lower risk groups and to define thresholds for optimal discrimination between the two. Two-year all-cause and cardiac mortality were not significantly different between IHF and NIHF subjects. Mortality was higher in patients with dysinnervation involving >50% of the myocardium. Highest cardiac mortality risk for IHF subjects was seen with perfusion defects involving 20-40% of the myocardium. By comparison, NIHF subjects with smaller perfusion abnormalities (<20% of myocardium), but with a large discrepancy between (123)I-mIBG and (99m)Tc tetrofosmin defect sizes, were at highest risk of cardiac death.
CONCLUSIONS: Prognostic significance of patterns of (123)I-mIBG and MPI uptake differ between IHF and NIHF subjects. SPECT imaging may provide new insights into underlying disease processes in HF, including the degree of dysinnervation in areas with preserved myocardial perfusion in non-ischaemic HF patients. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  SPECT myocardial imaging; heart failure; sympathetic dysinnervation

Mesh:

Substances:

Year:  2015        PMID: 26588983     DOI: 10.1093/ehjci/jev295

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  6 in total

1.  Phase dyssynchrony and 123I-meta-iodobenzylguanidine innervation imaging towards standardization.

Authors:  Kenichi Nakajima; Koichi Okuda; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2017-09-18       Impact factor: 5.952

2.  The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure.

Authors:  Anna I Mishkina; Victor V Saushkin; Tariel A Atabekov; Svetlana I Sazonova; Vladimir V Shipulin; Samia Massalha; Roman E Batalov; Sergey V Popov; Konstantin V Zavadovsky
Journal:  J Nucl Cardiol       Date:  2022-07-14       Impact factor: 3.872

3.  Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera.

Authors:  Kenichi Nakajima; Koichi Okuda; Kunihiko Yokoyama; Tatsuya Yoneyama; Shiro Tsuji; Hiroyuki Oda; Mitsuhiro Yoshita; Koji Kubota
Journal:  Ann Nucl Med       Date:  2017-07-08       Impact factor: 2.668

4.  A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.

Authors:  Derk O Verschure; Edwin Poel; Mark I Travin; Milena J Henzlova; Diwakar Jain; Arnold F Jacobson; Hein J Verberne
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-08-22       Impact factor: 9.130

Review 5.  Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation.

Authors:  D O Verschure; B L F van Eck-Smit; G A Somsen; R J J Knol; H J Verberne
Journal:  Neth Heart J       Date:  2016-12       Impact factor: 2.380

Review 6.  The prognostic value of 123I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.

Authors:  Mariano Pontico; Gabriele Brunotti; Miriam Conte; Ferdinando Corica; Laura Cosma; Cristina De Angelis; Maria Silvia De Feo; Julia Lazri; Antonio Matto; Melissa Montebello; Arianna Di Rocco; Viviana Frantellizzi; Alessio Farcomeni; Giuseppe De Vincentis
Journal:  J Nucl Cardiol       Date:  2021-01-13       Impact factor: 3.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.